U.S. stocks lower as investors rotate out of tech ahead of Jackson Hole
In a challenging market environment, Dun & Bradstreet (NYSE:DNB_old) Holdings Inc. (DNB) stock has recorded a new 52-week low, dipping to $8.77. The data analytics and business intelligence company has faced headwinds over the past year, reflected in a significant 1-year change with a decrease of 14.46%. Investors are closely monitoring the stock as it navigates through the current economic landscape, which has pressured the company’s performance and investor sentiment. The 52-week low marks a critical point for Dun & Bradstreet as it looks to implement strategies to rebound from the recent downturn and regain its footing in the competitive data analytics sector.
In other recent news, Dun & Bradstreet reported its fourth-quarter 2024 earnings, which fell short of expectations for both earnings per share (EPS) and revenue. The company recorded a modest revenue growth of less than 1% for the quarter, reaching $632 million, while the full-year revenue for 2024 showed a 3% increase. Adjusted EBITDA for the quarter was slightly down at $260 million, although the full year saw a 4% increase to $927 million. Despite these setbacks, Dun & Bradstreet is focusing on strategic initiatives and product innovations, including AI-powered solutions and risk analytics, to drive long-term growth.
Analysts at Needham and Raymond (NSE:RYMD) James both reduced their price targets for Dun & Bradstreet shares to $14.00, citing the company’s recent financial performance and ongoing strategic review. However, both firms maintained positive ratings, with Needham keeping a Buy rating and Raymond James a Strong Buy rating. They expressed confidence in the company’s intrinsic value and potential for future growth through strategic actions, such as mergers and acquisitions.
Dun & Bradstreet announced that it plans to update stakeholders on its strategic review results in the first quarter of 2025, which could lead to significant transactions or reduce distractions for employees. The company’s management remains optimistic about achieving 5% to 7% organic growth in the medium term, despite facing challenges such as revenue delays due to the strategic review and macroeconomic pressures. Analysts continue to see potential in the company’s underlying value and strategic initiatives, which are expected to enhance growth prospects.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.